Keyphrases
Cardiovascular Comorbidities
20%
Cholesterol LDL
20%
Drug Utilization
20%
Fasting Plasma Glucose
40%
First Year
20%
Glucose Metabolism
20%
Glucose-lowering Drugs
20%
Glycated Hemoglobin
20%
Glycemic Profile
100%
Hemoglobin A1c (HbA1c)
40%
Imatinib
100%
Imatinib Therapy
20%
LDL Cholesterol
20%
Lipid Profile
100%
Metabolic Benefits
20%
Patients with Diabetes
20%
Retrospective Cohort Study
100%
Second-line Treatment
20%
Statin Utilization
20%
Triglycerides
40%
Biochemistry, Genetics and Molecular Biology
Animal Model
16%
Cohort Study
100%
Comorbidity
16%
Glucose Blood Level
33%
Glucose Metabolism
16%
Glycated Hemoglobin
16%
Imatinib
100%
Lipid Profile
100%
Statin
16%
Triglyceride
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Comorbidity
16%
Drug Utilization
16%
Glycosylated Hemoglobin
16%
Hemoglobin A1c
16%
Imatinib
100%
Low Density Lipoprotein Cholesterol
16%
Statin (Protein)
16%
Triacylglycerol
33%
Food Science
Cholesterol
50%
Glucose Blood Level
100%
Glycosylated Hemoglobin
50%